Mattia D'Agostino Selected Research

Fibrosis (Cirrhosis)

1/2023

High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mattia D'Agostino Research Topics

Disease

20	Multiple Myeloma 12/2023 - 04/2016
8	Neoplasms (Cancer) 08/2023 - 01/2018
3	Neutropenia 12/2021 - 01/2020
2	Infections 12/2021 - 01/2021
1	Disease Progression 08/2023
1	COVID-19 02/2023
1	Leiomyoma (Uterine Fibroids) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Leiomyosarcoma 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Pneumonia (Pneumonitis) 12/2021
1	Fragile X Syndrome (Martin Bell Syndrome) 11/2021
1	Neurodevelopmental Disorders 11/2021
1	Autism Spectrum Disorder 11/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Residual Neoplasm 12/2020
1	Frailty 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2018
1	Plasma Cell Leukemia 01/2017

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 12/2023 - 01/2019
4	Bortezomib (Velcade)FDA Link 08/2023 - 12/2020
4	Lenalidomide (CC 5013)FDA Link 12/2021 - 01/2020
3	Melphalan (Alkeran)FDA LinkGeneric 12/2021 - 01/2020
3	daratumumabIBA 12/2021 - 01/2019
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 12/2020
2	Proteasome InhibitorsIBA 08/2023 - 01/2019
2	carfilzomibIBA 08/2023 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 01/2020
2	Eukaryotic Initiation Factor-4EIBA 11/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 12/2020 - 01/2020
2	AntigensIBA 11/2020 - 01/2019
1	SP2509IBA 08/2023
1	GraphiteIBA 02/2023
1	Eukaryotic Translation Initiation Factor 5AIBA 01/2023
1	Fibronectins (Fibronectin)IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	AlbuminsIBA 01/2022
1	Thalidomide (Thalomid)FDA Link 12/2021
1	PlatinumIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 11/2020
1	Bispecific AntibodiesIBA 11/2020
1	SteroidsIBA 01/2020
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2020
1	Alkylating AgentsIBA 01/2020
1	thiamine triphosphorate (TTP)IBA 01/2020
1	Immunomodulating AgentsIBA 01/2019
1	felzartamabIBA 01/2019
1	isatuximabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2018
1	LigandsIBA 01/2018
1	Investigational DrugsIBA 06/2017

Therapy/Procedure

9	Therapeutics 12/2023 - 04/2016
3	Immunotherapy 12/2021 - 01/2017
2	Stem Cell Transplantation 12/2021 - 01/2021
1	Autologous Transplantation 12/2021
1	Transplantation 12/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Salvage Therapy 01/2018